Advertisement

Importance of Knowing Lead and Patient Interaction

  • Raffaele De Lucia
  • Giovanni Coluccia
  • Stefano Viani
  • Luca Paperini

Abstract

The implantable cardiac pacemaker (PM)/defibrillator is a technically sophisticated system composed of a generator connected to one or more leads. Pacemaker/defibrillator leads play a pivotal role for system function, delivering the output pulse or the endocardial shock from the generator to the myocardium and acquiring spontaneous intracardiac electrogram from the heart to the device. Leads are also the most frequently involved component in case of system malfunction, and when a generator-pocket infection is present, their extraction — always necessary to guarantee complete resolution — is a challenge. The success of lead extraction is highly influenced by lead characteristics; for that reason, this chapter is dedicated to lead technology, i.e., polarity, electrodes, fixation mechanisms, electrode-tissue interaction, conductors, insulators, and connectors, with particular attention to aspects that may interfere with the extraction procedure. We discuss separately cardiac PM and defibrillator leads to emphasize their different technology.

Keywords

Silicone Rubber Superior Vena Cava Subclavian Vein Venous Obstruction Pace Lead 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Cuvillier E (2009) Handbook of leads for pacing, defibrillation & cardiac resynchronization. Eric Cuvillier, Juana DìazGoogle Scholar
  2. 2.
    Barold SS, Stroobant RX, Sinnaewe AF (2004) Cardiac pacemaker step by step — an illustrated guide. Blackwell, MaldenCrossRefGoogle Scholar
  3. 3.
    Amundson DC, McArthur W, Mosharrafa M (1979) The porous endocardial electrode. Pacing Clin Electrophysiol 2(1):40–50PubMedCrossRefGoogle Scholar
  4. 4.
    MacCarter DJ, Lundberg KM, Corstjens JP (1983) Porous electrodes: concept technology and results. Pacing Clin Electrophysiol 6(2 Pt 2): 427–435PubMedCrossRefGoogle Scholar
  5. 5.
    Skalsky M, Maddison D (1985) Evaluation of a new low polarisation high impedence Pt/Ir coated porous 6 mm 2 dish electrode. Pacing Clin Electrophysiol 8:788 [abstract]Google Scholar
  6. 6.
    Garberoglio B, Inguaggiato B, Chinaglia B, Cerise O (1983) Initial results with an activated pyrolytic carbon tip electrode. Pacing Clin Electrophysiol 6(2 Pt 2): 440–448PubMedCrossRefGoogle Scholar
  7. 7.
    Mugica J, Henry L, Attuel P et al (1986) Clinical experience with 910 carbon tip leads: comparison with polished platinum leads. Pacing Clin Electrophysiol 9(2 Pt 2):1230–1238PubMedCrossRefGoogle Scholar
  8. 8.
    Thuesen L, Jensen PJ, Vejby-Christensen H et al (1989) Lower chronic stimulation threshold in the carbon-tip than in the platinum-tip endocardial electrode: a randomized study. Pacing Clin Electrophysiol 12(10):1592–1595PubMedCrossRefGoogle Scholar
  9. 9.
    Mond H, Hunt D (1990) A second generation steroid eluting electrode Cardiostim 90. RBM Seventh International Congress Nice 12:62Google Scholar
  10. 10.
    Danilovic D, Breivik K, Hoff PI, Ohm OJ (1997) Clinical performance of steroid-eluting pacing leads with 12-mm2 electrodes. Pacing Clin Electrophysiol 20(11):2799–2809PubMedCrossRefGoogle Scholar
  11. 11.
    Hua W, Mond HG, Strathmore N (1997) Chronic steroideluting lead performance: a comparison of atrial and ventricular pacing. Pacing Clin Electrophysiol 20(1 Pt 1):17–24PubMedCrossRefGoogle Scholar
  12. 12.
    Jenney C, Tan J, Karicherla A et al (2005) A new insulation material for cardiac leads with potential for improved performance. Heart Rhythm 2:S318–S319CrossRefGoogle Scholar
  13. 13.
    Calfee RV, Saulson SH (1986) A voluntary standard for 32 mm unipolar and bipolar pacemaker leads and connectors. Pacing Clin Electrophysiol 9(6 Pt 2):1181–1185PubMedCrossRefGoogle Scholar
  14. 14.
    Mirowski M, Reid PR, Mower MM et al (1980) Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 303(6):322–324PubMedCrossRefGoogle Scholar
  15. 15.
    Haqqani HM, Mond HG (2009) The implantable cardioverter-defibrillator lead: principles, progress, and promises. Pacing Clin Electrophysiol 32:1336–1353PubMedCrossRefGoogle Scholar
  16. 16.
    Wilkoff BL, Belott PH, Love CJ et al (2005) Improved extraction of ePTFE and medical adhesive modified defibrillation leads from the coronary sinus and great cardiac vein. Pacing Clin Electrophysiol 28(3):205–211PubMedCrossRefGoogle Scholar
  17. 17.
    Kouht AR, Grammes J (2009) The ePTFE coated ICD leads are easier to remove than standard ICD leads up to 50 months implant duration. Hearth Rhythm 6(5):S132 [abstract]Google Scholar
  18. 18.
    Di Cori A, Bongiorni MG, Zucchelli G et al (2010) Transvenous extraction performance of expanded polytetrafluoroethylene-covered ICD leads in comparison to traditional ICD leads in humans. Pacing Clin Electrophysiol [Epub ahead of print]Google Scholar
  19. 19.
    Helland J, St Jude Medical Personal communicationGoogle Scholar
  20. 20.
    Hauser RG, Cannom D, Hayes DL et al (2002) Long-term structural failure of coaxial polyurethane implantable cardioverter defibrillator leads, Pacing Clin Electrophysiol 25(6):879–882PubMedCrossRefGoogle Scholar
  21. 21.
    Krahn AD, Champagne J, Healey JS et al (2008) Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Device Advisory Committee. Heart Rhythm 5(5):639–642PubMedCrossRefGoogle Scholar
  22. 22.
    Epstein AE, Baker JH 2nd, Beau SL et al (2009) Performance of the St Jude Medical Riata leads. Heart Rhythm 2009 6(2):204–209PubMedCrossRefGoogle Scholar
  23. 23.
    Kay GN, Brinker JA, Kawanishi DT et al (1999) Risks of spontaneous injury and extraction of an active fixation pacemaker lead: report of the Accufix Multicenter Clinical Study and Worldwide Registry. Circulation 100(23):2344–2352PubMedCrossRefGoogle Scholar
  24. 24.
    Fortescue EB, Berul CI, Cecchin F et al (2004) Patient procedural and hardware factors associated with pacemaker lead failures in pediatrics and congenital heart disease. Heart Rhythm 1(2):150–159PubMedCrossRefGoogle Scholar
  25. 25.
    Ellenbogen KA, Wood MA, Shepard RK et al (2003) Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. J Am Coll Cardiol 41(1):73–80PubMedCrossRefGoogle Scholar
  26. 26.
    Knight BP, Desai A, Coman J et al (2004) Long-term retention of cardiac resynchronization therapy. J Am Coll Cardiol 44(1):72–77PubMedCrossRefGoogle Scholar
  27. 27.
    Bongiorni MG, DI Cori A, Zucchelli G et al (2010) A modified transvenous single mechanical dilatation technique to remove a chronically implanted active-fixation coronary sinus pacing lead. Pacing Clin Electrophysiol [Epub ahead of print]Google Scholar
  28. 28.
    Holmes DR Jr (1986) Permanent pacemaker implantation. In: Furman S, Hayes DL, Holmes DR Jr (eds) A practice of cardiac pacing. Futura, Mount Kisco, pp 97–127Google Scholar
  29. 29.
    Ellenbogen KA, Wood MA (2005) Cardiac pacing and ICDs 4th edn, BlackwellGoogle Scholar
  30. 30.
    Ellestad MH, French J (1989) Iliac vein approach to permanent pacemaker implantation. Pacing Clin Electrophysiol 12(7 Pt 1):1030–1033PubMedCrossRefGoogle Scholar
  31. 31.
    García Guerrero JJ, De La Concha Castañeda JF, Fernández Mora G et al (2005) Permanent transfemoral pacemaker: a single-center series performed with an easier and safer surgical technique. Pacing Clin Electrophysiol 28(7):675–679PubMedCrossRefGoogle Scholar
  32. 32.
    Kennergren C (2008) European perspective on lead extraction: part II. Heart Rhythm 5(2):320–323PubMedCrossRefGoogle Scholar
  33. 33.
    Vellani CW, Tildesley G, Davies LG (1969) Endocardial pacing: a percutaneous method using the subclavian vein. Br Heart J 31(1):106–111PubMedCrossRefGoogle Scholar
  34. 34.
    Mobin-Uddin K, Smith PE, Lombardo C, Jude J (1967) Percutaneous intracardiac pacing through the subclavian vein. J Thorac Cardiovasc Surg 54(4):545–548PubMedGoogle Scholar
  35. 35.
    Jachuck SJ, Gill BS, Petty AH. (1974) Permanent cardiac pacing through the subclavian vein. Br J Surg 61(5):373–376PubMedCrossRefGoogle Scholar
  36. 36.
    Littleford PO, Spector SD (1979) Device for the rapid insertion of a permanent endocardial pacing electrode through the subclavian vein: preliminary report. Ann Thorac Surg 27(3):265–269PubMedCrossRefGoogle Scholar
  37. 37.
    Friesen A, Klein GJ, Kostuk WJ, Ahuja SP (1977) Percutaneous insertion of a permanent transvenous pacemaker electrode through the subclavian vein. Can J Surg 20(2):131–135PubMedGoogle Scholar
  38. 38.
    Kessinger JM, Holter AR, Geha AS (1982) Implantation of permanent transvenous pacemaker via subclavian vein. Arch Surg 117(8):1105–1107PubMedCrossRefGoogle Scholar
  39. 39.
    Vander Salm TJ, Haffajee CI, Okike ON (1981) Transvenous insertion of double sets of permanent electrodes through a single introducer: clinical application. Ann Thorac Surg 32(3):307–310CrossRefGoogle Scholar
  40. 40.
    Bernstein AD, Parsonnet V (1992) Survey of cardiac pacing in the United States in 1989. Am J Cardiol 69(4):331–338PubMedCrossRefGoogle Scholar
  41. 41.
    Goldman BS, Fraser JD, Morgan CD (1991) Survey of cardiac pacing in Canada. Can J Cardiol 7(9):391–398PubMedGoogle Scholar
  42. 42.
    Jacobs DM, Fink AS, Miller RP et al (1993) Anatomical and morphological evaluation of pacemaker lead compression. Pacing Clin Electrophysiol 16(3 Pt 1):434–444PubMedCrossRefGoogle Scholar
  43. 43.
    Magney JE, Flynn DM, Parsons JA et al (1993) Anatomical mechanisms explaining damage to pacemaker leads defibrillator leads and failure of central venous catheters adjacent to the sternoclavicular joint. Pacing Clin Electrophysiol 16(3 Pt 1):445–457PubMedCrossRefGoogle Scholar
  44. 44.
    Kleemann T, Becker T, Doenges K et al (2007) Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 115(19):2474–2480PubMedCrossRefGoogle Scholar
  45. 45.
    Takahashi T, Bhandari AK, Watanuki M et al (2002) High incidence of device-related and lead-related complications in the dual-chamber implantable cardioverter defibrillator compared with the single-chamber version. Circ J 66(8):746–750PubMedCrossRefGoogle Scholar
  46. 46.
    Smith MC, Love CJ (2008) Extraction of transvenous pacing and ICD leads. Pacing Clin Electrophysiol 31(6):736–752PubMedCrossRefGoogle Scholar
  47. 47.
    Rozmus G, Daubert JP, Huang DT et al (2005) Venous thrombosis and stenosis after implantation of pacemakers and defibrillators. J Interv Card Electrophysiol 13(1):9–19PubMedCrossRefGoogle Scholar
  48. 48.
    Contini C, Papi L, Pesola A et al (1973) Tissue reaction to intracavitary electrodes: effect on duration and efficiency of unipolar pacing in patients with A-V block. J Cardiovasc Surg (Torino) 14(3):282–290Google Scholar
  49. 49.
    Pauletti M, Pingitore R, Contini C (1979) Superior vena cava stenosis at site of intersection of two pacing electrodes. Br Heart J 42(4):487–489PubMedCrossRefGoogle Scholar
  50. 50.
    Esposito M, Kennergren C, Holmström N et al (2002) Morphologic and immunohistochemical observations of tissues surrounding retrieved transvenous pacemaker leads. J Biomed Mater Res 63(5):548–558PubMedCrossRefGoogle Scholar
  51. 51.
    Epstein AE, Kay GN, Plumb VJ et al (1998) Gross and microscopic pathological changes associated with nonthoracotomy implantable defibrillator leads. Circulation 98(15):1517–1524PubMedCrossRefGoogle Scholar
  52. 52.
    Byrd CL, Schwartz SJ, Hedin N (1991) Intravascular techniques for extraction of permanent pacemaker leads. J Thorac Cardiovasc Surg 101(6):989–997PubMedGoogle Scholar
  53. 53.
    Bongiorni MG, Soldati E, Zucchelli G et al (2008) Transvenous removal of pacing and implantable cardiac defibrillating leads using single sheath mechanical dilatation and multiple venous approaches: high success rate and safety in more than 2000 leads. Eur Heart J 29(23):2886–2893PubMedCrossRefGoogle Scholar
  54. 54.
    Korkeila P, Nyman K, Ylitalo A et al (2007) Venous obstruction after pacemaker implantation. Pacing Clin Electrophysiol 30(2):199–206PubMedCrossRefGoogle Scholar
  55. 55.
    Lickfett L, Bitzen A, Arepally A et al (2004) Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement. Europace 6(1):25–31PubMedCrossRefGoogle Scholar
  56. 56.
    Haghjoo M, Nikoo MH, Fazelifar AF et al (2007) Predictors of venous obstruction following pacemaker or implantable cardioverter-defibrillator implantation: a contrast venographic study on 100 patients admitted for generator change lead revision or device upgrade. Europace 9(5):328–332PubMedCrossRefGoogle Scholar
  57. 57.
    Aryana A, Sobota KD, Esterbrooks DJ, Gelbman AI (2007) Superior vena cava syndrome induced by endocardial defibrillator and pacemaker leads. Am J Cardiol 99(12):1765–1767PubMedCrossRefGoogle Scholar
  58. 58.
    Melzer C, Lembcke A, Ziemer S et al (2006) Pacemaker-induced superior vena cava syndrome: clinical evaluation of long-term follow-up. Pacing Clin Electrophysiol 29(12):1346–1351PubMedCrossRefGoogle Scholar
  59. 59.
    van Rooden CJ, Molhoek SG, Rosendaal FR et al (2004) Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads. J Cardiovasc Electrophysiol 15(11):1258–1262PubMedCrossRefGoogle Scholar
  60. 60.
    Sticherling C, Chough SP, Baker RL et al (2001) Prevalence of central venous occlusion in patients with chronic defibrillator leads. Am Heart J 141(5):813–816PubMedCrossRefGoogle Scholar
  61. 61.
    Bracke F, Meijer A, Van Gelder B (2003) Venous occlusion of the access vein in patients referred for lead extraction: influence of patient and lead characteristics. Pacing Clin Electrophysiol 26(8):1649–1652PubMedCrossRefGoogle Scholar
  62. 62.
    Worley SJ, Gohn DC, Pulliam RW (2008) Over the wire lead extraction and focused force venoplasty to regain venous access in a totally occluded subclavian vein. J Interv Card Electrophysiol 23(2):135–137PubMedCrossRefGoogle Scholar
  63. 63.
    Bakir I, La Meir M, Degrieck I et al (2005) Contralateral replacement of pacemaker and leads following laser sheath extraction and concomitant stenting for superior vena cava syndrome. Pacing Clin Electrophysiol 28(10):1131–1134PubMedCrossRefGoogle Scholar
  64. 64.
    Gilard M, Pérennes A, Mansourati J et al (2002) Stent implantation for the treatment of superior vena cava syndrome related to pacemaker leads. Europace 4(2):155–158PubMedCrossRefGoogle Scholar
  65. 65.
    Worley SJ (2008) Implant venoplasty: dilation of subclavian and coronary veins to facilitate device implantation: indications frequency methods and complications. J Cardiovasc Electrophysiol 19(9):1004–1007PubMedCrossRefGoogle Scholar
  66. 66.
    Borek PP, Wilkoff BL (2008) Pacemaker and ICD leads: strategies for long-term management. J Interv Card Electrophysiol 23(1):59–72PubMedCrossRefGoogle Scholar
  67. 67.
    Korley VJ, Hallet N, Daoust M, Epstein LM (2000) A novel indication for transvenous lead extraction: upgrading implantable cardioverter defibrillator systems. J Interv Card Electrophysiol 4(3):523–528PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2011

Authors and Affiliations

  • Raffaele De Lucia
    • 1
  • Giovanni Coluccia
    • 1
  • Stefano Viani
    • 1
  • Luca Paperini
    • 1
  1. 1.2nd Cardiovascular Department AOUPSanta Chiara University HospitalPisaItaly

Personalised recommendations